Anipamil for the treatment of chronic renal failure

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31075

Patent

active

050397095

ABSTRACT:
The use of anipamil and its salts with physiologically tolerated acids for the treatment of chronic renal failure is described.

REFERENCES:
patent: 4593042 (1985-10-01), Liang
patent: 4798811 (1988-01-01), Lehmann et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anipamil for the treatment of chronic renal failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anipamil for the treatment of chronic renal failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anipamil for the treatment of chronic renal failure will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1527695

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.